Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Periarticular Bupivacaine for Pain Control in Total Knee Replacement
NCT01364194Phase 4Completed
- Sponsor
- Mahidol University
- Start
- Mar 2010
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Mahidol University. Primary endpoint: Post operative pain at 96 hours. Started Mar 2010; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01364194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01364194.